Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Use Of Solid Lipid Nanoparticles For Sustained Drug Release.

A. Attama, C. Umeyor
Published 2015 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Novel solid lipid drug delivery systems such as solid lipid nanoparticles (SLN) have attracted wide and increasing attention in recent years. It has been sought as an interesting alternative drug delivery carrier system for bioactives for a variety of delivery routes. They show major advantages such as sustained release, improved bioavailability, improved drug incorporation and very wide application. This paper presents a discussion on the production protocols of SLN, lyophilization of SLN and delivery of SLN across the blood-brain barrier. Special attention was also paid to entrapment and release of drugs from SLN and strategies to enhance drug entrapment in SLN for sustained release. Analytical methods for the characterization of SLN were also discussed. Various routes of administration of SLN were presented as well as a consideration of the ethical issues and future prospects in the production and use of SLN for sustained release of bioactives.
This paper references
Pellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugs
J. F. Pinto (1999)
10.1080/02652040010018119
Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles.
M. Demirel (2001)
10.1016/j.ejps.2013.03.013
Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride.
H. Vaghasiya (2013)
10.1016/J.JCONREL.2004.04.026
Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
A. Vila (2004)
10.5772/50486
Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development
A. Attama (2012)
Transdermal Drug Delivery System: A Review
D. Patel (2012)
10.1016/j.jconrel.2005.09.052
Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting.
Huabing Chen (2006)
Investigation of diazepam lipospheres based on Witepsol and lecithin intended for oral or rectal delivery.
M. Sznitowska (2000)
10.1016/S0928-0987(98)00066-9
Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.
M. Chacón (1999)
10.1023/A:1015831801813
Polymorphic Behavior of Sprayed Lipid Micropellets and Its Evaluation by Differential Scanning Calorimetry and Scanning Electron Microscopy
T. Eldem (2004)
Solid Lipid Microparticles (SLMS): An Effective Lipid Based Technology for Controlled Drug Delivery
C. Kenechukwu (2012)
10.1016/S0378-5173(02)00325-3
Evaluation of controlled-release polar lipid microparticles.
M. Savolainen (2002)
10.1016/S0939-6411(03)00139-5
Freeze-drying polymeric colloidal suspensions: nanocapsules, nanospheres and nanodispersion. A comparative study.
S. R. Schaffazick (2003)
10.1016/J.JBIOTEC.2004.06.007
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1081/DDC-120001481
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
P. Lockman (2002)
Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles
HC Fessi (2015)
10.1016/S0378-5173(98)00379-2
Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens.
X. Li (1999)
10.1016/J.ADDR.2007.04.012
Nanostructured lipid carriers (NLC) in cosmetic dermal products.
R. Mueller (2007)
10.1208/pt050103
Nondestructive and on-line monitoring of tablets using light-induced fluorescence technology
C. K. Lai (2008)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/J.ADDR.2005.07.009
Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.
M. I. Ugwoke (2005)
Development of a controlled release formulation based on solid lipid nanoparticles and nanostructured lipid carriers for topical clotrimazole delivery
EB Souto (2004)
Drug Nanocrystals for Oral Delivery – Compounds by Spray Drying
FN Bushrab (1998)
10.1016/S0168-3659(98)00116-3
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
T. Govender (1999)
10.1016/S0939-6411(99)00075-2
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.
V. Jenning (2000)
10.1016/S0378-5173(01)00620-2
Development and characterization of lipid microparticles as a drug carrier for somatostatin.
H. Reithmeier (2001)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1016/0168-3659(96)01332-6
Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide)
R. Mehta (1996)
Thermal behaviour and polymorphism of acylglycerides
JW Hagemann
10.1201/9780203505281.CH3
Characterization of Solid Lipid Nano-and Microparticles
H. Bunjes (2004)
10.1016/J.IJPHARM.2005.09.007
Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS).
I. Friedrich (2005)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
TRANSDERMAL DRUG DELIVERY SYSTEM: REVIEW
Virendra Singh Yadav (2012)
10.1166/JNN.2008.274
New aspects of nanopharmaceutical delivery systems.
P. D. Marcato (2008)
10.1080/02652040010000361
Encapsulation of retinoids in solid lipid nanoparticles (SLN).
V. Jenning (2001)
EXPLORING SOLID LIPID NANOPARTICLES FOR INTRANASAL ADMINISTRATION OF STREPTOMYCIN
I. P. Kaur (2011)
10.4103/0250-474X.41456
Formulation and Targeting Efficiency of Cisplatin Engineered Solid Lipid Nanoparticles
R. Doijad (2008)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.4032/9789814669214
Design and development of approved nanopharmaceutical products
Raj Bawa (2016)
10.1016/j.ijpharm.2007.12.007
Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct.
A. Attama (2008)
Protein - loaded PLGA microparticles for oral administration : formulation , structural and release characteristics
H Rafati (1992)
10.5772/19290
Solid Lipid Nanoparticles: Technological Developments and in Vivo Techniques to Evaluate Their Interaction with the Skin
M. Bleve (2011)
10.4236/JBNB.2011.225075
Current State of Nanoemulsions in Drug Delivery
Charles Lovelyn (2011)
10.1016/S0939-6411(03)00067-5
Solid lipid nanoparticle and microemulsion for topical delivery of triptolide.
Zhinan Mei (2003)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1046/j.1467-2494.2001.00087.x
A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles
S. Wissing (2001)
10.33786/JCPR.2010.V01I01.015
Transdermal Drug Delivery System: A Review
.. A.Arunachalam (2010)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/S0168-3659(96)01475-7
Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics
H. Rafati (1997)
10.1016/S0196-9781(01)00537-X
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
K. Witt (2001)
10.1016/J.ADDR.2006.09.017
Freeze-drying of nanoparticles: formulation, process and storage considerations.
W. Abdelwahed (2006)
10.1208/pt050116
Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(I)lactide nanoparticles
L. Peltonen (2008)
Lysozyme - containing chitosancoated alginate microspheres for oral immunization
L Zorzin (2006)
10.1016/S0168-3659(01)00354-6
Lipid microparticles as a parenteral controlled release device for peptides.
H. Reithmeier (2001)
10.4103/2230-973X.133047
Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery
J. Madan (2014)
10.1016/S0939-6411(00)00125-9
Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
A. Saez (2000)
10.1016/S0168-3659(03)00120-2
Lipid microparticles as sustained release system for a GnRH antagonist (Antide).
M. D. Del Curto (2003)
10.1016/S1773-2247(06)50081-4
Lysozyme-containing chitosan-coated alginate microspheres for oral immunisation
L. Zorzin (2006)
10.1016/J.ADDR.2007.09.006
Approaches for the development of solid and semi-solid lipid-based formulations.
V. Jannin (2008)
10.1016/J.IJPHARM.2004.02.032
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
E. Souto (2004)
10.1002/JPS.10129
Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.
G. Zara (2002)
10.1016/0005-2736(73)90408-2
Single bilayer liposomes prepared without sonication.
S. Batzri (1973)
10.1016/J.JCONREL.2006.08.013
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
10.3109/08982104.2013.843192
Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery
Mahesh L Bikkad (2014)
10.4103/0250-474X.122883
Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation
S. G. Padhye (2013)
10.18433/J3NC79
Intranasal drug delivery: how, why and what for?
A. Pires (2009)
The theory of high-pressure homogenization
S. Jahnke (2001)
10.1016/J.ADDR.2005.07.005
The use of mucoadhesive polymers in ocular drug delivery.
A. Ludwig (2005)
10.1016/S0378-5173(02)00080-7
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.
R. Cavalli (2002)
10.1111/j.1471-4159.1993.tb03223.x
Peptidases, Peptides, and the Mammalian Blood–Brain Barrier
J. Brownlees (1993)
10.1155/2012/750891
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
P. Severino (2012)
10.1038/nrn1824
Astrocyte–endothelial interactions at the blood–brain barrier
N. Abbott (2006)
10.1208/s12249-009-9197-2
Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization
G. Abdelbary (2009)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1016/0378-5173(92)90303-J
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate
B. Sjoestroem (1992)
10.2147/IJN.S12125
Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
Z. Urbán-Morlán (2010)
10.1016/S0168-3659(99)00007-3
Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.
S. Yang (1999)
10.2174/187221107780831888
Nanotechnology: a new paradigm in cosmeceuticals.
I. P. Kaur (2007)
10.1023/B:PHAM.0000016234.73023.75
Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice
X. Tang (2004)
10.1023/A:1011975120776
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
A. Bargoni (2004)
10.1016/S0939-6411(97)00172-0
Spray-drying of solid lipid nanoparticles (SLN TM).
C. Freitas (1998)
10.1016/S0168-3659(02)00207-9
Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery
S. Barbault-Foucher (2002)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1007/s11095-013-1025-4
Brain Delivery of NAP with PEG-PLGA Nanoparticles Modified with Phage Display Peptides
J. Li (2013)
Chitosan nanoparticles : a new vehicle for the improvement of the ocular retention of drugs . Application to cyclosporin A
A DeCampos (2001)
10.1002/JPS.2600820608
A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. II: Influence of the emulsifier, the solvent, and the drug substance.
B. Sjoestroem (1993)
10.1016/S0142-9612(01)00362-3
Production of lipospheres as carriers for bioactive compounds.
R. Cortesi (2002)
10.1016/S0939-6411(01)00157-6
Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits.
M. Sznitowska (2001)
10.1208/pt070491
Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A
Pallavi V Pople (2008)
10.1201/9780849374555-4
Manufacturing of Nanoparticles by Milling and Homogenization Techniques
Rainer H. Mu€ller (2006)
10.3109/9781439825761-11
MECHANISMS OF PROTEIN STABILIZATION DURING FREEZE-DRYING AND STORAGE : THERELATIVE IMPORTANCE OF THERMODYNAMIC STABILIZATION AND GLASSY STATE RELAXAT ION DYNAMICS
M. Pikal (1999)
Drug Delivery to the Central Nervous System: A Review
R. Tamargo (1992)
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
M. Uner (2005)
10.1016/0168-3659(93)90097-O
Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior.
Toshiyuki (1993)
10.2174/187221111797200524
SLN, NLC, LDC: state of the art in drug and active delivery.
A. Attama (2011)
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
10.1023/A:1018992716621
The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and Without a Permeation Enhancer
W. Lee (2004)



This paper is referenced by
10.1021/acs.molpharmaceut.7b00676
Comparison across Three Hybrid Lipid-Based Drug Delivery Systems for Improving the Oral Absorption of the Poorly Water-Soluble Weak Base Cinnarizine.
P. Joyce (2017)
Comprehensive Review on Solid Lipid Nanoparticles
(2020)
10.1098/rsif.2017.0932
Overcoming clofazimine intrinsic toxicity: statistical modelling and characterization of solid lipid nanoparticles
Luíse L Chaves (2018)
SURFACE-MODIFIED BEESWAX-BASED NANO-LIPOGELS AS POTENTIAL DRUG DELIVERY SYSTEM: PRELIMINARY PHYSICOCHEMICAL CHARACTERIZATION FRANKLIN
F. Kenechukwu (2020)
10.1016/j.ejps.2017.12.006
Mannose‐functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages
A. Costa (2018)
10.2174/1573413714666180809120435
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review of the Effect of Physicochemical Formulation Factors in the Optimization Process, Different Preparation Technique, Characterization, and Toxicity
G. Poovi (2019)
10.1515/ejnm-2017-0010
Tailor-made mucoadhesive lipid nanogel improves oromucosal antimycotic activity of encapsulated miconazole nitrate
F. Kenechukwu (2017)
Development of new gene delivery carriers based on lipid nanoparticles
Telmo Pereira (2017)
10.1016/j.ejps.2016.05.012
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Eameema Muntimadugu (2016)
10.1515/ejnm-2016-0009
Solid lipid nanoparticles encapsulating a fluorescent marker (coumarin 6) and antimalarials – artemether and lumefantrine: evaluation of cellular uptake and antimalarial activity
A. Attama (2016)
10.1016/j.colsurfb.2020.111429
QbD-steered development of Biotin-Conjugated Nanostructured Lipid Carriers for Oral Delivery of Chrysin: Role of Surface Modification for Improving Biopharmaceutical Performance.
T. Sharma (2020)
10.1016/j.colsurfb.2018.01.046
Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
A. Nakhlband (2018)
10.1016/j.sjbs.2020.10.005
FbD directed fabrication and investigation of luliconazole based SLN gel for the amelioration of candidal vulvovaginitis: a 2 T (thermosensitive & transvaginal) approach
Salma Firdaus (2021)
Establishment of a three-dimensional in vitro model of air-blood barrier to assess the translocation of nanoparticles targeted to the lung
A. Costa (2018)
ajopred.com SOLIDIFIED REVERSE MICELLAR SOLUTION-BASED MUCOADHESIVE NANO-EMULGEL IMPROVES THE DISSOLUTION OF POORLY SOLUBLE IMIDAZOLE ANTIFUNGAL FRANKLIN CHIMAOBI KENECHUKWU*, MUMUNI AUDU MOMOH, GOD’SPOWER TOCHUKWU ISAAC, LILIAN CHINONSO NWEKWO, ANTHONY AMAECHI ATTAMA AND EMMANUEL CHINEDU IBEZIM
Franklin (2020)
10.1080/02652048.2017.1370029
Novel solidified reverse micellar solution-based mucoadhesive nano lipid gels encapsulating miconazole nitrate-loaded nanoparticles for improved treatment of oropharyngeal candidiasis
F. Kenechukwu (2017)
10.1016/B978-0-323-52725-5.00007-1
The Use of Nanotechnology in Modern Pharmacotherapy
A. Ostróżka-Cieślik (2017)
10.1177/1849543516673445
Development, in vitro and in vivo evaluations of novel lipid drug delivery system of Newbouldia laevis (P. Beauv.)
C. Umeyor (2016)
10.1080/03639045.2020.1752707
Oxiconazole nitrate solid lipid nanoparticles: formulation, in-vitro characterization and clinical assessment of an analogous loaded carbopol gel
R. Mahmoud (2020)
10.1016/j.foodchem.2017.06.019
Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Andreia Granja (2017)
10.1371/journal.pone.0187473
Antinociceptive antibiotics-loaded into solid lipid nanoparticles of prolonged release: Measuring pharmacological efficiency and time span on chronic monoarthritis rats
C. Valdés (2018)
10.1039/C6BM00276E
Recent trends on hydrogel based drug delivery systems for infectious diseases.
A. Vashist (2016)
10.1016/j.chemphyslip.2016.09.002
Synthesis and optimization of ceftriaxone-loaded solid lipid nanocarriers.
S. Kumar (2016)
10.1016/j.ijpharm.2017.04.025
Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen.
A. C. Marques (2017)
10.1080/21691401.2020.1770271
An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles
Khadijeh Khezri (2020)
Semantic Scholar Logo Some data provided by SemanticScholar